Literature DB >> 22818417

Is there an advantage in designing adapted, patient-specific PTV margins in intensity modulated proton beam therapy for prostate cancer?

Joanna Góra1, Markus Stock, Carola Lütgendorf-Caucig, Dietmar Georg.   

Abstract

PURPOSE: To investigate robust margin strategies in intensity modulated proton therapy to account for interfractional organ motion in prostate cancer. METHODS AND MATERIALS: For 9 patients, one planning computed tomography (CT) scan and daily and weekly cone beam CTs (CBCTs) were acquired and coregistered. The following planning target volume (PTV) approaches were investigated: a clinical target volume (CTV) delineated on the planning CT (CTV(ct)) plus 10-mm margin (PTV(10mm)); a reduced PTV (PTV(Red)): CTV(ct) plus 5 mm in the left-right (LR) and anterior-posterior (AP) directions and 8 mm in the inferior-superior (IS) directions; and a PTV(Hull) method: the sum of CTV(ct) and CTVs from 5 CBCTs from the first week plus 3 mm in the LR and IS directions and 5 mm in the AP direction. For each approach, separate plans were calculated using a spot-scanning technique with 2 lateral fields.
RESULTS: Each approach achieved excellent target coverage. Differences were observed in volume receiving 98% of the prescribed dose (V(98%)) where PTV(Hull) and PTV(Red) results were superior to the PTV(10mm) concept. The PTV(Hull) approach was more robust to organ motion. The V(98%) for CTVs was 99.7%, whereas for PTV(Red) and PTV(10mm) plans, V(98%) was 98% and 96.1%, respectively. Doses to organs at risk were higher for PTV(Hull) and PTV(10mm) plans than for PTV(Red), but only differences between PTV(10mm) and PTV(Red) were significant.
CONCLUSIONS: In terms of organ sparing, the PTV(10mm) method was inferior but not significantly different from the PTV(Red) and PTV(Hull) approaches. PTV(Hull) was most insensitive to target motion.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22818417     DOI: 10.1016/j.ijrobp.2012.05.046

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Scanned ion beam therapy for prostate carcinoma: Comparison of single plan treatment and daily plan-adapted treatment.

Authors:  Sebastian Hild; Christian Graeff; Antoni Rucinski; Klemens Zink; Gregor Habl; Marco Durante; Klaus Herfarth; Christoph Bert
Journal:  Strahlenther Onkol       Date:  2015-11-27       Impact factor: 3.621

2.  A patient-specific planning target volume used in 'plan of the day' adaptation for interfractional motion mitigation.

Authors:  Wenjing Chen; Alexander Gemmel; Eike Rietzel
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

3.  Positioning error and expanding margins of planning target volume with kilovoltage cone beam computed tomography for prostate cancer radiotherapy.

Authors:  Gang Wang; Wen-Ling Wang; Yi-Qun Liu; Hong-Min Dong; Yin-Xiang Hu
Journal:  Onco Targets Ther       Date:  2018-04-06       Impact factor: 4.147

4.  Normal Tissue Risk Estimation Using Biological Knowledge-Based Fuzzy Logic in Volumetric Modulated Arc Therapy of Prostate Cancer: Rectum.

Authors:  Santosh Kumar Patnaikuni; Sapan Mohan Saini; Rakesh Mohan Chandola; Pradeep Chandrakar; Vivek Chaudhary
Journal:  J Med Phys       Date:  2022-08-05

5.  Effects of the Bragg peak degradation due to lung tissue in proton therapy of lung cancer patients.

Authors:  Kilian-Simon Baumann; Veronika Flatten; Uli Weber; Stefan Lautenschläger; Fabian Eberle; Klemens Zink; Rita Engenhart-Cabillic
Journal:  Radiat Oncol       Date:  2019-10-25       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.